» Articles » PMID: 12817057

Clinical Prognostic Factors of Renal Outcome in Anti-neutrophil Cytoplasmic Autoantibody (ANCA)-associated Glomerulonephritis in Elderly Patients

Overview
Date 2003 Jun 21
PMID 12817057
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of the present study was to determine clinical prognostic factors on renal survival in 37 older patients with antineutrophil cytoplasmic autoantibody-associated pauci-immune necrotizing crescentic glomerulonephritis (ANCA-associated GN) who underwent renal biopsy at our Department between January 1996 and December 2000.

Methods: The date of renal biopsy was used as the start date for entry into the study. Age, gender, 24 h proteinuria, serum creatinine level, blood pressure and ANCA were evaluated. The end-point for renal survival analysis was the start of chronic dialysis.

Results: Twenty-six (70%) patients showed varying degrees of renal insufficiency, nine (24%) patients required dialysis, 13 (35%) were hypertensive (BP > or =140/90 mmHg) and 33 (89%) had proteinuria. During follow-up (31.73+/-17.39 months), 16% of the patients (6/37) developed end-stage renal disease (ESRD). The actuarial renal survival rate for all patients was 92% at 1 year and 76% at 3 years, for Wegener's granulomatosis 80% at 1 and 3 years, for microscopic polyangiitis 85% at 1 and 3 years, and for renal limited disease (GN) 75% at 1 and 37% at 3 years. Age (P = 0.024), arterial hypertension (P = 0.018), proteinuria (P = 0.037) and serum cre-atinine > or =400 micro mol/l (P = 0.047) were the most important risk factors for ESRD.

Conclusion: The actuarial renal survival rate in elderly patients with ANCA-associated GN was 92% at 1 year and 76% at 3 years. Older age, arterial hypertension, proteinuria and serum creatinine > or =400 micro mol/l related to ESRD.

Citing Articles

Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly.

Aqeel F, Xu L, Salas A, Wen Y, Eid S, Geetha D Clin Rheumatol. 2023; 42(9):2427-2435.

PMID: 37225927 PMC: 11128295. DOI: 10.1007/s10067-023-06644-2.


Long-term outcomes in elderly patients with ANCA-associated vasculitis.

McGovern D, Williams S, Parsons K, Farrah T, Gallacher P, Miller-Hodges E Rheumatology (Oxford). 2019; 59(5):1076-1083.

PMID: 31794032 PMC: 7671635. DOI: 10.1093/rheumatology/kez388.


[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Schirmer J, Aries P, Groot K, Hellmich B, Holle J, Kneitz C Z Rheumatol. 2017; 76(Suppl 3):77-104.

PMID: 29204681 DOI: 10.1007/s00393-017-0394-1.


Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.

Crnogorac M, Horvatic I, Toric L, Ljubanovic D, Tisljar M, Galesic K Int Urol Nephrol. 2017; 49(8):1419-1431.

PMID: 28646482 DOI: 10.1007/s11255-017-1610-2.


Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.

Hinojosa-Azaola A, Jimenez-Gonzalez A Clin Rheumatol. 2017; 36(9):1949-1957.

PMID: 28612242 DOI: 10.1007/s10067-017-3721-7.